PNC Financial Services Group
ERNA icon

PNC Financial Services Group’s Eterna Therapeutics ERNA Stock Holding History

PNC Financial Services Group’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1
Closed -$26K – 3990
2020
Q3 		$26K Sell
1
-1
-50% -$30.1K ﹤0.01% 3094
2020
Q2 		$66K Hold
2
– – ﹤0.01% 2602
2020
Q1 		$46K Hold
2
– – ﹤0.01% 2681
2019
Q4 		$66K Hold
2
– – ﹤0.01% 2732
2019
Q3 		$101K Hold
2
– – ﹤0.01% 2528
2019
Q2 		$114K Hold
2
– – ﹤0.01% 2479
2019
Q1 		$121K Hold
2
– – ﹤0.01% 2440
2018
Q4 		$59K Buy
2
+1
+100% +$47.4K ﹤0.01% 2776
2018
Q3 		$67K Hold
1
– – ﹤0.01% 2827
2018
Q2 		$67K Hold
1
– – ﹤0.01% 2800
2018
Q1 		$102K Hold
1
– – ﹤0.01% 2541
2017
Q4 		$63K Hold
1
– – ﹤0.01% 2811
2017
Q3 		$92K Hold
1
– – ﹤0.01% 2564
2017
Q2 		$102K Hold
1
– – ﹤0.01% 2502
2017
Q1 		$130K Hold
1
– – ﹤0.01% 2350
2016
Q4 		$128K Buy
+1
New +$120K ﹤0.01% 2333

Other funds holding ERNA

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PNC Financial Services Group's ERNA Position: Q4 2020 in Review

PNC Financial Services Group sold out of Eterna Therapeutics (ERNA) in Q4 2020, closing a stake of 1 share — an estimated $26K sold.

PNC Financial Services Group first reported a position in ERNA in Q4 2016 and held it in 16 quarters. The position peaked at $130K in Q1 2017. 5 funds tracked by Wall St. Rank hold ERNA as of Q4 2020.

  • PNC Financial Services Group reported no remaining Eterna Therapeutics position as of Q4 2020 after selling out during the quarter.
  • PNC Financial Services Group sold 1 Eterna Therapeutics share in Q4 2020, an estimated $26K.
  • PNC Financial Services Group first reported a position in Eterna Therapeutics in Q4 2016 and held it in 16 quarters.
  • PNC Financial Services Group's Eterna Therapeutics position peaked at $130K in Q1 2017.
  • 5 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q4 2020.

Based on PNC Financial Services Group's 13F filing for Q4 2020, filed 12 Feb 2021.